Exogenous Administration of PACAP Alleviates Traumatic Brain Injury in Rats through a Mechanism Involving the TLR4/MyD88/NF-κB Pathway
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Pituitary adenylate cyclase-activating polypeptide (PACAP) is effective in reducing axonal damage associated with traumatic brain injury (TBI), and has immunomodulatory properties. Toll-like receptor 4 (TLR4) is an important mediator of the innate immune response. It significantly contributes to neuroinflammation induced by brain injury. However, it remains unknown whether exogenous PACAP can modulate TBI through the TLR4/adapter protein myeloid differentiation factor 88 (MyD88)/nuclear factor-κB (NF-κB) signaling pathway. In this study, we investigated the potential neuroprotective mechanisms of PACAP pretreatment in a weight-drop model of TBI. PACAP38 was microinjected intracerebroventricularly before TBI. Brain samples were extracted from the pericontusional area in the cortex and hippocampus. We found that TBI induced significant upregulation of TLR4, with peak expression occurring 24 h post-trauma, and that pretreatment with PACAP significantly improved motor and cognitive dysfunction, attenuated neuronal apoptosis, and decreased brain edema. Pretreatment with PACAP inhibited upregulation of TLR4 and its downstream signaling molecules MyD88, p-IκB, and NF-κB, and suppressed increases in the levels of the downstream inflammatory agents interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), in the brain tissue around the injured cortex and in the hippocampus. Administration of PACAP both in vitro and in vivo attenuated the ability of the TLR4 agonist lipopolysaccharide (LPS) to increase TLR4 protein levels. Therefore, PACAP exerts a neuroprotective effect in this rat model of TBI, by inhibiting a secondary inflammatory response mediated by the TLR4/MyD88/NF-κB signaling pathway in microglia and neurons, thereby reducing neuronal death and improving the outcome following TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathophysiology of traumatic brain injury
Werner, C., & Engelhard, K. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem131 · Cited by 1,712
The epidemiology of traumatic brain injury: a review
Bruns, J., & Hauser, W. A. (2003) · Epilepsia · doi:10.1046/j.1528-1157.44.s10.3.x · Cited by 1,271 · cited 1×
“T raumatic brain injury (TBI) is a major factor leading to death and chronic disability in individuals under the age of 45 years worldwide (Bruns and Hauser, 2003; Tagliaferri et al., 2006; Werner and Engelhard, 2007).”
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Clinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913 · cited 2×
“…et al., 2004), albumins (Myburgh et al., 2007), magnesium sulfate (Temkin et al., 2007), calcium channel antagonists (e.g., nimodipine; Clausen and Bullock, 2001), excitatory amino acid inhibitors, and free radical scavengers (Narayan et al., 2002), have all been inefficient for TBI treatment.”
Toll-like Receptors in Defense and Damage of the Central Nervous System
Aravalli, R. N., Peterson, P. K., & Lokensgard, J. R. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9071-5 · Cited by 173 · cited 2×
“Emerging evidence demonstrates a central role for TLRs expressed on microglia as a pivotal factor in generating these neuroimmune responses (Aravalli et al., 2007).”
Kojro, E., Postina, R., Buro, C., Meiringer, C., Gehrig‐Burger, K., & Fahrenholz, F. (2006) · The FASEB Journal · doi:10.1096/fj.05-4812fje · Cited by 118 · cited 1×
“…system diseases/conditions, such as focal cerebral ischemia (Allais et al., 2010; Nakamachi et al., 2010; Stetler et al., 2010), Alzheimer’s disease (Kojro et al., 2006), schizophrenia (Matsuzaki and Tohyama, 2008; Tanaka et al., 2006), anxiety disorders (Choi et al., 2008; Norrholm et al., 2005),…”
Cited by
Li, X., Liu, L., Yang, J., Yu, Y., Chai, J., Wang, L., Ma, L., & Yin, H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.030 · Cited by 450
Zhu, H.-T., Bian, C., Yuan, J.-C., Chu, W.-H., Xiang, X., Chen, F., Wang, C.-S., Feng, H., & Lin, J.-K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-59 · Cited by 364
Reglodi, D., Renaud, J., Tamas, A., Tizabi, Y., Socías, S. B., Del-Bel, E., & Raisman-Vozari, R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.004 · Cited by 162
Zhang, L., Li, Y., Wu, X., Hong, Z., & Wei, W. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13021 · Cited by 113
Corrigan, F., Arulsamy, A., Collins-Praino, L. E., Holmes, J. L., & Vink, R. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.04.006 · Cited by 46
Metadata
- Authors
- Mao, S.-S., Hua, R., Zhao, X.-P., Qin, X., Sun, Z.-Q., Zhang, Y., Wu, Y.-Q., Jia, M.-X., Cao, J.-L., & Zhang, Y.-M.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2012-07
- Volume
- 29
- Issue
- 10
- Pages
- 1941-1959
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W2094715296
- Cited by
- 93
- References
- 6
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.